McKinsey to pay $650m to settle US opioid consulting probe. Prosecutors say McKinsey provided Purdue advice on measures it could take to ‘turbocharge’ OxyContin sales.

McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm's work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...

McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

McKinsey, which previously agreed to pay almost $1 billion to settle lawsuits by states, local governments and others related to its opioid consulting, accepted responsibility for the conduct ...

McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe ...

McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe ...

Consulting firm McKinsey & Co is close to an agreement with U.S. prosecutors to pay more than $500 million to resolve longstanding federal investigations into its past work helping opioid makers ...

Federal prosecutors have been investigating McKinsey's role in the opioid epidemic, focusing on its work advising OxyContin maker Purdue Pharma and other drugmakers, Reuters reported in April.

McKinsey & Co is in the final stages of negotiating a deferred prosecution agreement to resolve a U.S. criminal investigation into the consulting firm's work helping opioid manufacturers boost ...

McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...